ÂÜÀòÂÒÂ×

Kate Bailey Fox is an experienced professional in commercial strategy for biopharmaceutical companies, currently serving as Executive Director of Global Marketing for Blincyto at Amgen since July 2023. Previously held leadership positions include Interim Principal at Asymmetry Group LLC, Vice President of Commercial Planning at Atara Biotherapeutics, and Executive Director of Corporate Strategy and Planning at Gilead Sciences. Kate's earlier roles also include Assistant Director at Astellas Pharma and Associate Partner at Monitor Group. Academic credentials include an MBA in Marketing from Northwestern University's Kellogg School of Management, an MA in Political Science from Tulane University, and a BA in Latin American Studies and Political Science from the University of North Carolina at Chapel Hill.